Moss, 6 November 2026
Reference is made to the annual general meeting 6 May 2025 where guidelines for
remuneration of executive personnel were approved. In accordance with these
guidelines the board of Gentian Diagnostics ASA has allocated a total of 485,000
options to key employees under the existing option program.
The following number of options have been allocated to primary insiders of
Gentian Diagnostics ASA:
Matti Heinonen, Chief Executive Officer: 100,000 options with a strike price of
NOK 60.00 and 100,000 options with a strike price of NOK 44.00. Following the
grant, Mr. Heinonen holds 15,569 shares and 300,000 options in the Company.
Njaal Kind, Group Chief Financial Officer: 50,000 options with a strike price of
NOK 60.00 and 50,000 options with a strike price of NOK 44.00. Following the
allocation Mr. Kind holds 32,194 shares and 240,670 options in the Company.
Aleksandra Havelka, Chief Scientific Officer: 20,000 options with a strike price
of NOK 44.00. Following the allocation Ms. Havelka hold 2,920 shares and 100,000
options in the Company.
Hanne Kristiansen, Vice President Commercial: 20,000 options with a strike price
of NOK 60.00 and 20,000 options with a strike price of NOK 44.00. Following the
allocation Ms. Kristiansen holds 1,023 shares and 40,000 options in the Company.
The right to exercise the options is vested over a period of 2 years, with 50%
of the options vesting by the end of each year as follows: (i) 50% of the
options granted, no earlier than 3 years after the allocation date, (ii) 50% of
the options granted, no earlier than 4 years after the allocation date at an The
options may also be exercised at expiry after 5 years.
Attached are the notifications of the transactions pursuant to the market abuse
regulation article 19: Notifications of the transactions
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
For further information, please contact:
Njaal Kind CFO, Gentian Diagnostics ASA
E-mail: njaal.kind@gentian.no
Phone: +47 919 06 525